Compounds as GLP-IR agonists
US12410163B2 · kind B2 · utility
0Cited by
14References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2023 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | May 19, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application provides compounds that may be used as a glucagon-like peptide-1 receptors (GLP-1R) agonist, or pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions containing such compounds, or pharmaceutically acceptable salts thereof. Methods of preparing these compounds and compositions, and methods of using these compounds and compositions to treat or prevent a disease or a condition mediated by GLP-1R, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.